CytoDyn CYDY
OTC CYDY
$0.26 +0.02 (+9.09%)
As of: Oct 23, 2026 · 1:05 PM EDT

CytoDyn (CYDY) Gross Profit (2021)

Updated

CytoDyn (CYDY) posted Gross Profit of $213,000 for FY2022 (year ended May 31, 2022).

Analysis

CytoDyn (CYDY) Gross Profit (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 CytoDyn 355.23 Mn 306.38 Mn -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2021 173,000.00
Aug 31, 2021 40,000.00
API Access

CytoDyn Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CYDY&period=max&api_key=YOUR_API_KEY